Using Human Induced Pluripotent Stem Cells to Model Skeletal Diseases.

Area of Science:

• Stem cell biology
• Skeletal biology
• Genetics

Background:

• Musculoskeletal disorders pose significant health challenges, with genetic origins and diagnostic limitations hindering understanding.
• Human induced pluripotent stem cells (hiPSCs) provide a novel platform for modeling human skeletal diseases due to their self-renewal and differentiation capabilities.
• hiPSCs can incorporate disease-specific mutations or be genetically corrected, enabling the creation of precise disease models and isogenic controls.

Purpose of the Study:

• To review the application of hiPSCs in modeling rare musculoskeletal disorders, specifically fibrodysplasia ossificans progressive (FOP).
• To discuss protocols for differentiating hiPSCs towards the osteogenic lineage for skeletal disease modeling.
• To explore challenges and new approaches in utilizing hiPSCs for understanding abnormal skeletal formation and bone regeneration.

Main Methods:

• Differentiation of hiPSCs into the osteogenic lineage.
• Generation of hiPSC-based disease models, including those with specific mutations.
• Establishment of isogenic control lines through genetic correction of hiPSCs.

Main Results:

• Demonstrated successful differentiation of hiPSCs into osteogenic cells.
• Developed and applied hiPSC models for studying fibrodysplasia ossificans progressive (FOP).
• Identified critical factors and challenges in hiPSC-based skeletal disease modeling.

Conclusions:

• hiPSCs are a valuable tool for modeling skeletal diseases, offering insights into pathogenesis and potential therapeutic targets.
• Refined differentiation protocols enhance the utility of hiPSCs for skeletal biology research.
• Future advancements in hiPSC technology will further advance the understanding of skeletal formation and regeneration.